671 related articles for article (PubMed ID: 16984235)
1. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
2. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
Amin R; Williams RM; Frystyk J; Umpleby M; Matthews D; Orskov H; Dalton RN; Dunger DB
Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
Christiansen JJ; Gravholt CH; Fisker S; Svenstrup B; Bennett P; Veldhuis J; Andersen M; Christiansen JS; Jørgensen JO
Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
[TBL] [Abstract][Full Text] [Related]
7. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone and IGF-I in diabetic children with and without microalbuminuria.
Verrotti A; Cieri F; Petitti MT; Morgese G; Chiarelli F
Diabetes Nutr Metab; 1999 Aug; 12(4):271-6. PubMed ID: 10782753
[TBL] [Abstract][Full Text] [Related]
9. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
Ehrnborg C; Ohlsson C; Mohan S; Bengtsson BA; Rosén T
Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
[TBL] [Abstract][Full Text] [Related]
10. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
Peczyńska J; Urban M; Głowińska B; Urban B
Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
[TBL] [Abstract][Full Text] [Related]
11. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.
Kuan Y; Surman J; Frystyk J; El Nahas AM; Flyvbjerg A; Haylor JL
Growth Horm IGF Res; 2009 Jun; 19(3):219-25. PubMed ID: 19046909
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL
Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
16. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus.
Gannon MC; Nuttall FQ
Metabolism; 2011 Sep; 60(9):1300-11. PubMed ID: 21406307
[TBL] [Abstract][Full Text] [Related]
17. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
[TBL] [Abstract][Full Text] [Related]
18. Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial.
Graydon R; Gilchrist SE; Young IS; Obermüller-Jevic U; Hasselwander O; Woodside JV
Eur J Clin Nutr; 2007 Oct; 61(10):1196-200. PubMed ID: 17299493
[TBL] [Abstract][Full Text] [Related]
19. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
Duschek EJ; de Valk-de Roo GW; Gooren LJ; Netelenbos C
Fertil Steril; 2004 Aug; 82(2):384-90. PubMed ID: 15302288
[TBL] [Abstract][Full Text] [Related]
20. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]